EC Number   |
Inhibitors |
Structure |
|---|
    1.4.3.5 | 1-(propan-2-yl)-6-[2-[4-(propan-2-yl)phenoxy]ethoxy]-1,3-dihydro-2H-benzimidazol-2-one |
- |
 |
| 1.4.3.5 | 1-ethyl-6-[2-(3-fluorophenoxy)ethoxy]-1,3-dihydro-2H-benzimidazol-2-one |
- |
|
| 1.4.3.5 | 1-ethyl-6-[2-[4-(propan-2-yl)phenoxy]ethoxy]-1,3-dihydro-2H-benzimidazol-2-one |
- |
|
| 1.4.3.5 | 1-ethyl-6-[[4-(trifluoromethyl)phenyl]methoxy]-1,3-dihydro-2H-benzimidazol-2-one |
- |
|
| 1.4.3.5 | 1-methyl-6-(3-phenylpropoxy)-1,3-dihydro-2H-benzimidazol-2-one |
- |
|
| 1.4.3.5 | 2,3-Butanedione |
10 mM, complete inhibition after 50 min in borate buffer, inhibition is fully reversible upon removal of borate |
  |
| 1.4.3.5 | 2,4-pentandione |
0.3 mM, approx. 90% inhibition of holoenzyme |
|
| 1.4.3.5 | 4-chloromercuribenzoate |
0.1 mM, 90-95% inhibition |
|
| 1.4.3.5 | 4-deoxypyridoxine 5'-phosphate |
0.1 mM, 42% inhibition |
|
| 1.4.3.5 | 4-deoxypyridoxine 5'-phosphate |
- |
|
